Sinus Head Congestion Capsule, Liquid Filled
NDC Package 82706-025-01
Package Information
Sinus Head Congestion (acetaminophen, phenylephrine hydrochloride) capsules is take only as directed (see overdose warning)do not exceed 8 softgels per 24 hrsadults and children 12 years and over2 softgels with water every 4 hourschildren 4 to under 12 yearsconsult a doctorchildren under 4 yearsdo not use. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Vivunt Pharma Llc, this product is identified by NDC 82706-025 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1052670 - acetaminophen 325 MG / phenylephrine HCl 5 MG Oral Capsule
- RxCUI: 1052670 - acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule
- RxCUI: 1052670 - APAP 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 82706 - Vivunt Pharma Llc
- 82706-025 - Sinus Head Congestion
- 82706-025-01 - 3 BLISTER PACK in 1 CARTON / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
- 82706-025 - Sinus Head Congestion
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82706-025-01 identifies a specific commercial package of 3 blister pack in 1 carton / 8 capsule, liquid filled in 1 blister pack of Sinus Head Congestion, a human over the counter drug labeled by Vivunt Pharma Llc. This capsule, liquid filled is formulated for oral use and contains acetaminophen; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Vivunt Pharma Llc on March 18, 2025. The current certification is valid through December 31, 2026.
How is this Vivunt Pharma Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82706002501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.